The anti-depressant drug Zoloft has been a prime cash generator for the pharmaceutical giant Pfizer since it first received approval from the FDA for use in the United States in 1991.
When it comes to personal injuries suffered by patients in hospitals and nursing homes in New Jersey and throughout the country, emphasis is commonly placed on preventable medical errors -- things like facility negligence, medication errors, hospital-acquired infections and other mistakes that experts say can and routinely should be prevented.
It's good that London-based GlaxoSmithKline Plc (GSK), one of the world's largest pharmaceutical manufacturers, is awash in money, because the company is certainly spending it to settle criminal and civil investigations into illegal marketing and product liability matters.
A professor and traffic safety expert at one university calls the concept of accident-free cars "very hot" and says that the technology enabling them will be sufficiently advanced to allow such vehicles to begin operating on some roads and highways in the near foreseeable future.
We informed readers in a prior blog post (please see our October 23 entry) that we would keep them fully apprised of material developments unfolding regarding the nation's tragic meningitis outbreak that first surfaced last month.
Most people have heard recent news reports regarding a Salmonella outbreak caused by peanut butter now being sold in Trader Joe's stores throughout the nation and even right here in Bergen County. The supermarket chain has ordered a voluntary recall of the tainted peanut butter as a precautionary measure.
Crystal Springs Resort, the owner and managing operator of the Mountain Creek Waterpark in Vernon, is likely concerned with issues relating to both premises liability and product liability in the aftermath of an accident that occurred at the park in mid-summer.
Calling it a "landmark settlement," one state attorney general from among 35 other s pitted against New Jersey-based pharmaceutical giant Johnson & Johnson (J&J) lauds the recent settlement between J&J and the U.S. Food and Drug Administration (FDA), which also includes the three dozen plaintiff states.
Multiple news sources are reporting that persons closely familiar with the Johnson & Johnson (J&J) DePuy ASR hip implant litigation say that the New Jersey-based pharmaceutical giant has reached settlements with three plaintiffs in the first product liability lawsuits slated for trial in state court.